Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewa Harasim-Symbor

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Therapeutic Advances in Chronic Disease|January 13, 2023
How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseasesSylwia Dziemitko, Ewa Harasim-Symbor, Adrian Chabowski
Frontiers in Endocrinology|March 21, 2020
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on CannabidiolPatrycja Bielawiec, Ewa Harasim-Symbor, Adrian Chabowski
Cells|July 11, 2025
Short-Term Incubation of H9c2 Cardiomyocytes with Cannabigerol Attenuates Diacylglycerol Accumulation in Lipid Overload ConditionsSylwia Dziemitko, Adrian Chabowski, Ewa Harasim-Symbor
Journal of Molecular Endocrinology|October 7, 2016
Additive effects of dexamethasone and palmitate on hepatic lipid accumulation and secretionEwa Harasim-Symbor, Karolina Konstantynowicz-Nowicka, Adrian Chabowski
Advances in Medical Sciences|July 17, 2022
Are fatty acids and fatty acid binding proteins novel biomarkers for cryoablation efficiency?Karolina Golaszewska, Ewa Harasim-Symbor, Bartlomiej Lukaszuk, et al.
Frontiers in Physiology|May 2, 2019
How Hypertension Affects Heart MetabolismAgnieszka Polak-Iwaniuk, Ewa Harasim-Symbor, Karolina Gołaszewska, et al.
The Journal of Nutritional Biochemistry|February 22, 2025
Cannabidiol and sphingolipid metabolism - an unexplored link offering a novel therapeutic approach against high-fat diet-induced hepatic insulin resistanceKarolina Konstantynowicz-Nowicka, Klaudia Sztolsztener, Adrian Chabowski, et al.
Biochemical and Biophysical Research Communications|November 21, 2021
The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitateKlaudia Sztolsztener, Ewa Harasim-Symbor, Adrian Chabowski, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 11, 2024
Cannabigerol as an anti-inflammatory agent altering the level of arachidonic acid derivatives in the colon tissue of rats subjected to a high-fat high-sucrose dietKlaudia Sztolsztener, Ewa Harasim-Symbor, Adrian Chabowski, et al.
International Journal of Molecular Sciences|November 27, 2021
Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLDKlaudia Sztolsztener, Karolina Konstantynowicz-Nowicka, Ewa Harasim-Symbor, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Therapeutic Advances in Chronic Disease|January 13, 2023
How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseasesSylwia Dziemitko, Ewa Harasim-Symbor, Adrian Chabowski
Frontiers in Endocrinology|March 21, 2020
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on CannabidiolPatrycja Bielawiec, Ewa Harasim-Symbor, Adrian Chabowski
Cells|July 11, 2025
Short-Term Incubation of H9c2 Cardiomyocytes with Cannabigerol Attenuates Diacylglycerol Accumulation in Lipid Overload ConditionsSylwia Dziemitko, Adrian Chabowski, Ewa Harasim-Symbor
Journal of Molecular Endocrinology|October 7, 2016
Additive effects of dexamethasone and palmitate on hepatic lipid accumulation and secretionEwa Harasim-Symbor, Karolina Konstantynowicz-Nowicka, Adrian Chabowski
Advances in Medical Sciences|July 17, 2022
Are fatty acids and fatty acid binding proteins novel biomarkers for cryoablation efficiency?Karolina Golaszewska, Ewa Harasim-Symbor, Bartlomiej Lukaszuk, et al.
Frontiers in Physiology|May 2, 2019
How Hypertension Affects Heart MetabolismAgnieszka Polak-Iwaniuk, Ewa Harasim-Symbor, Karolina Gołaszewska, et al.
The Journal of Nutritional Biochemistry|February 22, 2025
Cannabidiol and sphingolipid metabolism - an unexplored link offering a novel therapeutic approach against high-fat diet-induced hepatic insulin resistanceKarolina Konstantynowicz-Nowicka, Klaudia Sztolsztener, Adrian Chabowski, et al.
Biochemical and Biophysical Research Communications|November 21, 2021
The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitateKlaudia Sztolsztener, Ewa Harasim-Symbor, Adrian Chabowski, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 11, 2024
Cannabigerol as an anti-inflammatory agent altering the level of arachidonic acid derivatives in the colon tissue of rats subjected to a high-fat high-sucrose dietKlaudia Sztolsztener, Ewa Harasim-Symbor, Adrian Chabowski, et al.
International Journal of Molecular Sciences|November 27, 2021
Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLDKlaudia Sztolsztener, Karolina Konstantynowicz-Nowicka, Ewa Harasim-Symbor, et al.
Pageof 7